Treatment of inherited protein C deficiency by replacement therapy with the French purified plasma-derived protein C concentrate (PROTEXEL®)

Vox Sanguinis

Volumn 93, Issue 3, 2007, Pages 233-240

  Dreyfus, M ^a   Ladouzi, A ^b   Chambost, H ^c   Gruel, Y ^d   Tardy, B ^e   Ffrench, P ^f   Bridey, F ^b   Tellier, Z ^b   Conard, J ^g   Kiffer, B ^h   Viard, P ⁱ   Borel Derlon, A ^j   Lequerrec, A ^j  

^a BICÊTRE HOSPITAL   (France)

^b Laboratoire Francais du Fractionnement et des Biotechnologies   (France)

^c TIMONE HOSPITAL   (France)

^d SERVICE DE DERMATOLOGIE   (France)

^e UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^f Louis Pradel's Cardiovascular Hospital   (France)

^g HÔTEL DIEU   (France)

^h Centre Hospitalier Regional Metz Thionville   (France)

ⁱ Rodez Hospital   (France)

^j CAEN UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Disseminated intravascular coagulation; Inherited protein C deficiency; Protein C concentrate; Purpura fulminans; Replacement therapy

Indexed keywords

ANTIVITAMIN K; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN C; PROTEXEL; UNCLASSIFIED DRUG; WARFARIN;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FASCIOTOMY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL; PROTEIN C DEFICIENCY; SUBSTITUTION THERAPY; THROMBOSIS;

EID: 34548491155     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2007.00953.x     Document Type: Article

References (21)

1. Humphries JE : Thrombophilia and complex acquired deficiencies of antithrombin, protein C, and protein S. Semin Hematol 1995 32 : 8 16
2. Esmon C : The protein C pathway. Crit Care Med 2000 28 : S44 S48
3. Kafali G, Tanzer F, Yildiz E : Neonatal purpura fulminans due to homozygous protein C deficiency. J Trop Pediatr 1998 44 : 122 123
4. Seligsohn U, Berger A, Abend M, Attias D, Zivelin A, Rapaport SI : Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984 310 : 559 562
5. Marlar RA, Kleiss AJ, Griffin JH : Diagnosis and treatment of homozygous protein C deficiency. J Pediatr 1989 114 : 528 532
6. Schramm W, Spannagl M, Bauer KA, Rosenberg RD, Birkner B, Linnau Y, Schwarz HP : Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrate. Arch Dermatol 1993 129 : 753 756
7. Lewandowski K, Zawilska K : Protein C concentrate in the treatment of warfarin-induced skin necrosis in the protein C deficiency. Thromb Haemost 1994 71 : 395
8. Simmelink MJ, de Groot PG, Derksen RH, Fernandez JA, Griffin JH : Oral anticoagulation reduces activated protein C less than protein C and other vitamin K-dependent clotting factors. Blood 2002 100 : 4232 4233
9. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C : Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981 68 : 1370 1373
10. Sanson BJ, Simioni P, Tormene D, Moia M, Friederich PW, Huisman MV, Prandoni P, Bura A, Rejto L, Wells P, Mannucci PM, Girolami A, Buller HR, Prins MH : The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood 1999 94 : 3702 3706
11. Dreyfus M, Magny JF, Bridey F, Schwarz HP, Planche C, Dehan M, Tchernia G : Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991 325 : 1565 1568
12. Auberger K : Evaluation of a new protein C concentrate and comparison of protein C assays in a child with congenital protein C deficiency. Ann Hematol 1992 64 : 146 151
13. Marlar RA, Sils RH, Groney PK, Montgomery RR, Madden RM : Protein C survival during replacement therapy in homozygous protein C deficiency. Am J Hematol 1992 41 : 24 31
14. Baliga V, Thwaites R, Tillyer ML, Minford A, Parapia L, Allgrove J : Homozygous protein C deficiency-management with protein C concentrate. Eur J Pediatr 1995 154 : 534 538
15. Dreyfus M, Masterson M, David M, Rivard GE, Muller FM, Kreuz W, Beeg T, Minford A, Allgrove J, Cohen JD, Christoph J, Bergmann F, Mitchell VE, Haworth C, Nelson K, Schwarz HP : Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency. Semin Thromb Hemost 1995 21 : 371 381
16. Muller FM, Ehrentahal W, Hafner G, Schranz D : Purpura fulminans in severe congenital protein C deficiency: monitoring of treatment with protein C concentrate. Eur J Pediatr 1996 155 : 20 25
17. Paret G, Barzilai A, Barzilai Z : Purpura fulminans skin lesions in a newborn with complete protein C deficiency. J Pediatr 1998 132 : 558
18. European Union Directive on Data Protection : Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the protection of individuals with regard to the processing of personal data and on the free movement of such data. Official J Eur Commun 1995 L.281 : 31
19. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L : Maturation of the hemostatic system during childhood. Blood 1992 80 : 1998 2005
20. Conard J, Bauer KA, Gruber A, Griffin JH, Schwarz HP, Horellou MH, Samama MM, Rosemberg R : Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency. Blood 1993 82 : 1159 1164
21. Moritz B, Rogy S, Tonetta S, Engl W, Naim R, Schwarz HP, Gomperts E, Ehrlich H the protein C Study Group. The efficacy and safety of protein C concentrate (human) vapor-heated in the treatment of severe congenital protein C deficiency with or without purpura fulminans. Blood 2000 96 : 53a